At Deloitte Legal, key areas of instruction for the team include development and license agreements, product distribution issues, and MDR-related matters. The group is equally strong in assisting with investment work in the life sciences space. Ghent-based practice head Matthias Vierstraete is a key contact for trade mark, patent, and data protection law. In the Brussels office, Christoph Michiels has longstanding experience in assisting medtech and biotech start-up clients with commercial and IP-related work. Jean-Christophe Top left the firm in January 2024.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is experienced and very effective.’
Key clients
- Nipro Medical Europe NV
- Nipro Digital Technologies Europe NV
- The Akkermansia Company SA
- S-Biomedic NV
- Indigo Diabetes NV
- D-Tek NV
- eTheRNA Immunotherapies NV
- UC-Leuven Limburg
- European Cystic Fybrosis Society
- Belgian State, FPS Public Health
- Yun NV
- Amphistar BV
- Aphea.Bio NV
- Rejuvenate Biomed NV
Work highlights
- Advised Yun NV on distribution agreements.
- Assisted an international syndicate of investors with an equity investment round in Amphistar.
- Advised the client on negotiations for a master service agreement with a contract research organisation for long term collaboration concerning clinical trials.
Practice head
The lawyer(s) leading their teams.
Matthias Vierstraete